The liver doesn't just process what you eat and filter what your blood carries, it apparently runs something closer to a scheduled broadcast operation, sending specific chemical messages to the rest of the body at specific, predictable times of day. A study published June 2, 2026, in Nature Communications, from researchers at UT Health San Antonio, and reported more widely starting August 12, 2026, mapped that schedule in detail for the first time, and found it's considerably more rigid than scientists previously appreciated.

A question that sounds simple but wasn't easy to answer

Researchers have long known the liver secretes hepatokines, signaling proteins released into the bloodstream that help coordinate metabolic activity across the body, communicating with tissues like fat and muscle to help regulate how the body stores and burns energy. What remained poorly understood was whether that secretion happened on any kind of predictable schedule, or whether the liver simply released these proteins as needed, responding reactively to whatever metabolic conditions happened to be present at a given moment.

Christopher Litwin, a fourth-year PhD student in the lab of researcher Andrew Koronowski and the study's first author, explained the gap the team set out to close. "It was known that the liver regulates the secretion of some of these proteins," Litwin said, "but they lacked a developed measure of how and when proteins were released." The research team's underlying hypothesis was that timing itself might matter considerably for how these proteins actually function, since a signal arriving at the wrong moment relative to a target tissue's own metabolic state could plausibly have a very different effect than the same signal arriving on a coordinated schedule.

Building a method to actually catch proteins in the act of release

To investigate that question, the research team developed what they describe as an ex vivo approach specifically compatible with tracking activity across the circadian, or roughly 24-hour, timescale, allowing them to observe liver protein secretion at different points across the daily cycle rather than relying on a single snapshot measurement. Working with liver tissue from both male and female mice, researchers excised samples during two key phases of the daily cycle: the inactive, fasting phase, and the active, feeding phase, capturing secretion patterns during both.

That approach let researchers systematically catalog hundreds of secreted proteins and determine, for each one, whether its release followed a time-of-day-dependent pattern or occurred at a relatively constant rate regardless of the hour. The proteomic analysis identified secreted molecules involved in a wide range of biological functions, including extracellular matrix maintenance, immune response, redox balance, processing of foreign substances, and fatty acid metabolism, giving researchers a considerably broader view of the liver's secretory activity than prior, less time-resolved studies had captured.

A genuinely strict schedule, not a loose pattern

The results confirmed the research team's underlying hypothesis in a fairly dramatic way. Many of the identified proteins showed time-of-day-dependent or clock-dependent secretion, meaning their release wasn't simply responsive to immediate metabolic conditions but instead followed a schedule tied directly to the liver's own internal circadian clock. According to Litwin, that schedule proved consistently structured: proteins tended to be released either specifically during active periods or specifically during periods of rest, rather than showing a loose or inconsistent pattern across the day.

Extracellular matrix proteins, which help form the structural support framework within which cells and organs sit, were specifically released during rest periods, according to the UT Health San Antonio research team's findings, one concrete example of the broader pattern of functionally organized, time-specific secretion the study documented across the liver's wider secreted protein output.

One protein in particular stood out

Among the hundreds of proteins tracked, one specific molecule drew particular attention from the research team: endostatin, a cleavage product derived from a larger structural protein called collagen type XVIII alpha 1. According to the study, the liver secretes more endostatin specifically during the inactive, fasting phase of the daily cycle, a pattern tightly regulated by the liver's core circadian clock machinery.

That regulation traces back to a specific molecular clock component called BMAL1, one of the core proteins driving circadian rhythm generation throughout the body. When researchers examined what happened to endostatin's timed secretion pattern in the absence of functioning BMAL1, they found the timing became disrupted through two combined mechanisms: reduced transcriptional activity of the gene encoding the endostatin precursor protein, and altered proteolytic processing, the biochemical step that cleaves the larger precursor protein down into active endostatin itself.

What endostatin actually appears to do once released

Having identified endostatin's precisely timed release pattern, researchers then tested what functional effect the protein has once it reaches its target tissue. Functional experiments conducted both in living animals and in isolated cell cultures revealed that endostatin suppresses mitochondrial gene expression, effectively dampening the activity of genes responsible for cellular energy production within the cells it reaches. That finding gives researchers a concrete functional link between the timing of a specific liver-secreted protein and a measurable downstream metabolic effect, rather than simply documenting a timing pattern without understanding its biological consequence.

Why timing itself might matter as much as the signal

The study's broader significance lies in what it suggests about how metabolic signaling actually works throughout the body: not simply through the presence or absence of a given hormone or protein, but through the specific timing of when that signal arrives relative to a coordinated, clock-driven schedule. Litwin framed the underlying implication directly: "The core idea is that the clock regulates protein secretion and can influence metabolism across the day, and in other tissues."

That framing carries real potential relevance for how future metabolic treatments might eventually be designed and administered. If a signaling protein like endostatin only exerts its intended metabolic effect when released or administered at a specific point in the daily cycle, then a therapy based on that same protein or pathway might similarly need to be timed carefully to achieve its intended benefit, rather than administered without regard to time of day, as most current medications are.

A field already interested in when, not just what

This finding fits within a broader and growing area of research called chronotherapy, the study of how the timing of medical treatments, whether medication dosing, meal timing, or other interventions, can meaningfully affect their overall effectiveness. Researchers investigating circadian biology across multiple organ systems have increasingly found that many physiological processes operate on tightly regulated daily schedules, and that disrupting those schedules, through irregular eating patterns, shift work, or other factors, can itself contribute to metabolic dysfunction over time.

The UT Health San Antonio team's specific contribution adds a detailed, protein-level map of exactly how one of the body's most metabolically active organs structures its own signaling output across the day, giving chronotherapy researchers a considerably more granular foundation to build from than simply knowing that circadian disruption correlates with worse metabolic health generally.

Where this research is headed next

Beyond documenting the current findings, the research team has indicated they intend to continue investigating related signaling molecules with therapeutic potential. Koronowski described the lab's broader ambition directly: "We are interested in developing and characterizing novel peptides. We want to find the next GLP-1 drug, or even something better that is waiting to be discovered." That framing situates the current study's detailed circadian secretion mapping as part of a longer-term search for new metabolic drug targets, following the model established by GLP-1 receptor agonist medications, which have already transformed treatment for diabetes and obesity by working with, rather than against, the body's existing metabolic signaling systems.

What this means for understanding metabolic disease going forward

For a field increasingly focused on precision and timing in treating metabolic conditions like obesity, diabetes, and fatty liver disease, this study offers a genuinely detailed foundation connecting circadian clock biology directly to specific, functionally significant liver-secreted proteins. Understanding not just which molecules the liver releases, but precisely when and how that timing is regulated at the molecular level, gives researchers considerably more specific handles to potentially manipulate, whether by developing new time-targeted therapies or by better understanding how disrupted eating and sleep patterns might themselves interfere with the liver's carefully coordinated metabolic broadcast schedule.

---

*Sources cited in this article include the peer-reviewed study "Timed secreted proteomes reveal regulation of hepatokines by the liver circadian clock," published June 2, 2026, in Nature Communications, and reporting from UT Health San Antonio's official press release, MedicalXpress, Technology Networks, Bioengineer.org, and News-Medical.net covering research led by Christopher Litwin and Andrew Koronowski. All figures reflect reporting available as of August 20, 2026.*